Ahmed bin Mohammed inaugurates the “DUPHAT 2024” conference and exhibition within the largest session in its history

Today, His Highness Sheikh Ahmed bin Mohammed bin Rashid Al Maktoum, Second Deputy Ruler of Dubai, opened the activities of the 29th session of the Dubai International Pharmaceutical and Technology Conference and Exhibition – “DUPHAT 2024”, which is the largest in the history of the exhibition, which is held at the Dubai World Trade Center with the participation of more than 1,300 companies. International and specialized, as the exhibition is expected to witness the participation and attendance of more than 32 thousand visitors and participants from 95 countries around the world, over the three days of the event, which is the largest gathering of pharmaceutical companies in the Middle East and Africa.

His Highness Sheikh Ahmed bin Mohammed bin Rashid Al Maktoum stressed that the prosperity of the exhibitions and conferences sector in Dubai is the result of diligent work aimed at creating all the data that enables companies of all sizes and international business institutions of all specializations to benefit from the great potential that Dubai has in terms of advanced logistical capabilities. And world-class service facilities and highly efficient and reliable infrastructure, which together contributed to consolidating Dubai’s position as a pivotal meeting point for those in charge of industries and various commercial and development activities to provide the latest products and solutions, thus making Dubai a pivotal center for launching global partnerships and deals that support the economic prospects of many vital sectors.
His Highness, the Second Deputy Ruler of Dubai, toured the exhibition, which included a number of pavilions and platforms of international, Arab and Emirati companies participating in the largest sessions of the DUPHAT exhibition, where His Highness was briefed on the pharmaceutical products, solutions, applications and modern technologies it displays in the field of pharmaceutical industries.
His Highness listened to an explanation about the cultural and cognitive activities included in the event through lectures and workshops that will be hosted and attended by more than 150 speakers who will present 120 lectures and 16 workshops over the course of its three days, while the DUPHAT Conference and Exhibition will receive a number of university students who will display 350 posters. Scientifically based on the latest medical research and innovations in the sector.
The opening was attended by His Excellency Abdul Rahman Al Owais, Minister of Health and Community Protection, His Excellency Helal Saeed Al Marri, Director General of the Department of Economy and Tourism, Director General of the Dubai World Trade Center Authority, His Excellency Awad Saghir Al Ketbi, Director General of the Dubai Health Authority, Dr. Amer Al Sharif, Executive Director of Dubai Health, and His Excellency Ambassador Dr. Abdul Salam Al Madani, CEO of DUPHAT Conference and Exhibition, and a number of heads of delegations and companies participating in the event.
His Excellency Ambassador Dr. Abdul Salam Al Madani, CEO of the DUPHAT Conference and Exhibition, stressed the importance of the pharmaceutical sector as a vital element in the economy with the growing levels of health care for the population and the rapid development of the health care system. He said: The Dubai International Pharmaceutical and Technology Conference and Exhibition is a vital platform for exchanging advanced knowledge and experiences, as it plays a pivotal role in enhancing the skills necessary to drive growth in this dynamic industry. This year’s DUPHAT 2024 session outperformed its previous sessions in terms of attendance, participation, and innovations that are beneficial to everyone, whether on the medical level. Or commercial, while the pharmaceutical industry in the UAE and the region is witnessing continuous growth, and provides unprecedented business opportunities.
Market studies indicate that the value of the pharmaceutical market in the UAE is expected to exceed $4.7 billion by the year 2025, with a remarkable growth of 27% over the past five years, as the country provides more than 2,500 locally produced medicines, which reflects the strong and distinctive manufacturing capacity of the country. UAE in the pharmacy sector. Global estimates also indicate that the value of the Middle East and North Africa market exceeds 50 billion US dollars, which strengthens the region’s position in the pharmacy sector and the pharmaceutical industry globally. The role of the DUPHAT Conference and Exhibition is not limited to being a pharmaceutical event, but goes beyond that to embody… An inspiring journey where knowledge meets innovation.
Over the course of 28 years, the role of the DUPHAT Conference and Exhibition has been demonstrated as a unique global platform that brings together an elite group of experts in the pharmaceutical sector by providing exceptional facilities for pharmaceutical suppliers and industry leaders to present the latest pharmaceutical products, technologies and solutions, and opportunities to exchange information, ideas, visions and innovations in the pharmaceutical sector, in addition to showcasing everything He is new regarding medications and patient care.
A number of the most prominent and largest pharmaceutical companies in the world, such as Pfizer, AstraZeneca, GlaxoSmithKline (GSK), Gilead, Julphar, Axios, Haleon, AbbVie, and Lilly, will participate in the activities of the DUPHAT 2024 Conference and Exhibition.
The Dubai International Pharmaceuticals and Technology Conference and Exhibition – DUPHAT 2024 is organized by INDEX Conferences and Exhibitions – a member of INDEX Holding, with the support of the Dubai Health Authority, the American Society of Health-System Pharmacists, the International Society of Pharmacology, the European Federation of Pharmaceutical Sciences, the European Society for Clinical Pharmacy, and the Society of Hospital Pharmacists of Australia. And the European Society of Oncology Pharmacology.